FR2462477B1 - - Google Patents

Info

Publication number
FR2462477B1
FR2462477B1 FR7919652A FR7919652A FR2462477B1 FR 2462477 B1 FR2462477 B1 FR 2462477B1 FR 7919652 A FR7919652 A FR 7919652A FR 7919652 A FR7919652 A FR 7919652A FR 2462477 B1 FR2462477 B1 FR 2462477B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7919652A
Other versions
FR2462477A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7919652A priority Critical patent/FR2462477A1/fr
Priority to JP10378480A priority patent/JPS5622793A/ja
Priority to GB8024949A priority patent/GB2060645B/en
Priority to CH581980A priority patent/CH645130A5/fr
Priority to NL8004406A priority patent/NL8004406A/nl
Priority to DE19803029111 priority patent/DE3029111A1/de
Publication of FR2462477A1 publication Critical patent/FR2462477A1/fr
Application granted granted Critical
Publication of FR2462477B1 publication Critical patent/FR2462477B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/22—Klebsiella
FR7919652A 1979-07-31 1979-07-31 Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant Granted FR2462477A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7919652A FR2462477A1 (fr) 1979-07-31 1979-07-31 Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
JP10378480A JPS5622793A (en) 1979-07-31 1980-07-30 Novel sugar protein from klebsiella pneumoniae* method of obtaining it* use as drug and composition containing it
GB8024949A GB2060645B (en) 1979-07-31 1980-07-30 Glycoproteins extracted from klebsiella pneumoniae
CH581980A CH645130A5 (fr) 1979-07-31 1980-07-30 Glycoproteines de klebsiella pneumoniae, leur procede d'obtention et medicaments les renfermant.
NL8004406A NL8004406A (nl) 1979-07-31 1980-07-31 Nieuwe glycoproteinen van klebsiella pneumoniae, werkwijze voor hun bereiding, hun toepassing als geneesmiddelen en samenstellingen, die deze glycoproteinen bevatten.
DE19803029111 DE3029111A1 (de) 1979-07-31 1980-07-31 Neue glykoproteine von klebsiella pneumoniae, verfahren zu deren herstellung, deren verwendung als arzneimittel und die diese enthaltenden zusammensetzungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7919652A FR2462477A1 (fr) 1979-07-31 1979-07-31 Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
FR2462477A1 FR2462477A1 (fr) 1981-02-13
FR2462477B1 true FR2462477B1 (fr) 1983-12-30

Family

ID=9228477

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7919652A Granted FR2462477A1 (fr) 1979-07-31 1979-07-31 Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant

Country Status (6)

Country Link
JP (1) JPS5622793A (fr)
CH (1) CH645130A5 (fr)
DE (1) DE3029111A1 (fr)
FR (1) FR2462477A1 (fr)
GB (1) GB2060645B (fr)
NL (1) NL8004406A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
FR2396020A1 (fr) * 1977-07-01 1979-01-26 Cassenne Lab Sa Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses d'hafnia, d'aerobacter cloacae et de klebsiella pneumoniae, procede de preparation et application a titre de medicaments de ces produits

Also Published As

Publication number Publication date
DE3029111C2 (fr) 1990-03-22
JPS6363560B2 (fr) 1988-12-07
JPS5622793A (en) 1981-03-03
FR2462477A1 (fr) 1981-02-13
DE3029111A1 (de) 1981-02-19
CH645130A5 (fr) 1984-09-14
GB2060645B (en) 1983-03-23
GB2060645A (en) 1981-05-07
NL8004406A (nl) 1981-02-03

Similar Documents

Publication Publication Date Title
DE2927086C2 (fr)
BR8002583A (fr)
BR8006808A (fr)
FR2446747B1 (fr)
FR2462477B1 (fr)
DE2917478C2 (fr)
DE3033500C2 (fr)
DE3016468C2 (fr)
FR2447914B1 (fr)
FR2446030B1 (fr)
DE2903644C2 (fr)
FR2447403B3 (fr)
DE2939382C2 (fr)
FR2446281B1 (fr)
FR2447140B1 (fr)
AT364253B (fr)
FR2447113B3 (fr)
AU78270S (fr)
AU78271S (fr)
AU77669S (fr)
BR5901094U (fr)
AU77763S (fr)
AU78385S (fr)
JPS5673439U (fr)
BG29934A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse